Literature DB >> 10428735

Risk for colorectal cancer after gynecologic cancer.

D S Weinberg1, C J Newschaffer, A Topham.   

Abstract

BACKGROUND: Studies have suggested that women with previous diagnoses of gynecologic cancer (cervical, endometrial, or ovarian) have an increased risk for colorectal cancer.
OBJECTIVE: To quantify risk for colorectal cancer after gynecologic cancer, both overall and for subgroups defined by age at diagnosis, cancer stage at diagnosis, ethnicity, and duration of follow-up.
DESIGN: Retrospective cohort analysis of the Surveillance, Epidemiology, and End Results (SEER) program database from 1974 through 1995.
SETTING: U.S. cancer registry. PATIENTS: 21,222 patients with cervical cancer, 51,680 patients with endometrial cancer, and 28,832 patients with ovarian cancer. MEASUREMENTS: Standardized incidence ratios (SIRs) were calculated for each gynecologic cancer site and for subgroups to represent the relative risk for colorectal cancer in women with previously diagnosed gynecologic cancer compared with women without gynecologic cancer. Poisson regression methods adjusting simultaneously for all study variables were used to estimate relative risks for colorectal cancer across subgroups with each gynecologic cancer.
RESULTS: Overall, risk for colorectal cancer was elevated among women with previous ovarian cancer (SIR, 1.36 [95% CI, 1.21 to 1.53]). Risk was greatest in women who received a diagnosis before 50 years of age (SIR, 3.67 [CI, 2.74 to 4.80]) but was also elevated in women who received a diagnosis between 50 and 64 years of age (SIR, 1.52 [CI, 1.25 to 1.83]). The risk for colorectal cancer after endometrial cancer was also elevated substantially if endometrial cancer was diagnosed before the age of 50 (SIR, 3.39 [CI, 2.73 to 4.17]). No apparent risk elevation was associated with previous cervical cancer.
CONCLUSIONS: Previous endometrial or ovarian cancer, particularly when diagnosed at an early age, increases subsequent risk for colorectal cancer. Greater emphasis on colorectal cancer screening in these populations may be necessary.

Entities:  

Mesh:

Year:  1999        PMID: 10428735     DOI: 10.7326/0003-4819-131-3-199908030-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

Review 1.  Second malignancies among elderly survivors of cancer.

Authors:  Ari M VanderWalde; Arti Hurria
Journal:  Oncologist       Date:  2011-10-31

Review 2.  Sex- and gender-specific disparities in colorectal cancer risk.

Authors:  Sung-Eun Kim; Hee Young Paik; Hyuk Yoon; Jung Eun Lee; Nayoung Kim; Mi-Kyung Sung
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 3.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

4.  Increased cumulative incidence of prostate malignancies in colorectal cancer patients.

Authors:  Nuri Ozden; Murat Saruc; Lynette M Smith; Arthi Sanjeevi; Hemant K Roy
Journal:  Int J Gastrointest Cancer       Date:  2003

5.  Screening mammography rate and predictors following treatment for colorectal cancer.

Authors:  A Marshall McBean; Xinhua Yu; Beth A Virnig
Journal:  J Cancer Surviv       Date:  2009-02-18       Impact factor: 4.442

Review 6.  Improving survival after endometrial cancer: the big picture.

Authors:  Janice S Kwon
Journal:  J Gynecol Oncol       Date:  2015-07       Impact factor: 4.401

7.  Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.

Authors:  Ji-Bin Li; Zhi-Yu Qiu; Yu-Xiang Deng; Yin Li; Zhuo-Chen Lin; Yan-Ping Wu; Fan Weng; Huan Tian; Qing-Jian Ou; Cheng-Hua Gong; Zhi-Zhong Pan; De-Sen Wan; Jian-Hong Peng; Yu-Jing Fang
Journal:  Discov Oncol       Date:  2022-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.